A new study of how phages disarm dangerous bacteria could lead to new treatments for bacterial infections, researchers report.

Initially developed in the 1950s, nitazenes are a type of synthetic opioid that has reappeared in Philadelphia’s street drug supply.

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

‘Natural’ isn’t the same thing as healthful. You can have too much of a good thing, and taking action can be worse than doing nothing.

Researchers have discovered a safer and more efficient technique for testing new drugs while they are in development.

Some tattoo inks contain unlabeled materials that can cause allergic reactions.

People have been battling tuberculosis for thousands of years, and drug-resistant strains are on the rise. Analyzing large datasets with AI can help humanity gain a crucial edge over the disease.

When enzymes go rogue, they can cause a range of diseases, including cancers. A new platform could reveal molecules that target them.

New research opens leads in anti-HIV drug development, using a compound found in nature.